| Drug Name | (Aclasta®( Zoledronic acid |
|---|---|
| Drug Class |
Anti-osteoporotic
|
| Risk minimization type |
Patient Card
Direct Healthcare Professional Communication DHPC
Healthcare provider guide
|
| Specialty (Theraputic area) |
Musculoskeletal Diseases
|
| Risk |
Risk of acute renal impairment Risk of osteonecrosis of the jaw (ONJ) |
| Patient card |
|
| Health care provider guide |
|
| Dear Healthcare provider letter DHPC |
|